Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers
The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
Nishizuka, Y. (1992) · Science · doi:10.1126/science.1411571 · Cited by 4,472
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1982) · Biochemical Journal · doi:10.1042/bj2060587 · Cited by 2,136
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Papageorgis, D. (1991) · Behaviour Research and Therapy · doi:10.1016/0005-7967(91)90087-j · Cited by 1,534
Cited by
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Subcortical volumetric abnormalities in bipolar disorder
the Costa Rica/Colombia Consortium for Genetic Investigation of Bipolar Endophenotypes, Hibar, D. P., for the ENIGMA Bipolar Disorder Working Group, Westlye, L. T., van Erp, T. G. M., Rasmussen, J., Leonardo, C. D., Faskowitz, J., Haukvik, U. K., Hartberg, C. B., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.227 · Cited by 511
Stork, C., & Renshaw, P. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001711 · Cited by 477
Dudev, T., & Lim, C. (2014) · Chemical Reviews · doi:10.1021/cr4004665 · Cited by 451
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
Self-citationBaldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341
Zhou, R., Yuan, P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., Damschroder-Williams, P., Du, J., Chen, G., & Manji, H. K. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.131 · Cited by 316
Self-citationCellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 274
Self-citationReich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Leng, Y., Liang, M.-H., Ren, M., Marinova, Z., Leeds, P., & Chuang, D.-M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5467-07.2008 · Cited by 214
“In addition, the same GSK-3 inhibitor reduces amphetamine-induced hyperactivity in rats, a mania-like behavior (Gould et al., 2004).”
BackgroundLithium neuroprotection: molecular mechanisms and clinical implications
Rowe, M. K., & Chuang, D.-M. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404008385 · Cited by 197
Marmol, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.012 · Cited by 174
“Inhibition of GSK-3 levels by lithium has been proposed as a possible therapy fordifferentdiseases suchasAlzheimerdisease andother neurodegenerative disorders (Tong et al., 2002; Chuanget al., 2002;Gould et al., 2004b; Zhong and Lee, 2007).”
Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression
Benedetti, F., Radaelli, D., Poletti, S., Locatelli, C., Falini, A., Colombo, C., & Smeraldi, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.006 · Cited by 165
“…of glycogen synthase kinase-3beta (GSK3β) protects against cell death, and an excessive activation promotes apoptosis (Benedetti et al., 2010; Gould et al., 2004): lithium inhibits GSK3β (Benedetti et al., 2005; Gould and Manji, 2005), which is abnormally active in the ventral prefrontal…”
BackgroundRandomized Double-Blind Placebo-Controlled Trial of Lithium in Youths with Severe Mood Dysregulation
Dickstein, D. P., Towbin, K. E., Van Der Veen, J. W., Rich, B. A., Brotman, M. A., Knopf, L., Onelio, L., Pine, D. S., & Leibenluft, E. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.044 · Cited by 148
The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics
O’Donnell, K. C., & Gould, T. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.002 · Cited by 137
Self-citationAnimal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136
Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder
Zarate, C. A., & Manji, H. K. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00003 · Cited by 122
“diabetic complications [see Gould et al.[77] for a review]) and are possible candidates to test in bipolar disorder (see table II).”
Self-citationThe potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69
A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation
Frederick, J. P., Tafari, A. T., Wu, S.-M., Megosh, L. C., Chiou, S.-T., Irving, R. P., & York, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801182105 · Cited by 67
“BPNT1 belongs to a structurally conserved, lithium-inhibited family of small-molecule phosphomonoesterases, which in addition to glycogen synthase kinase, have been implicated as possible cellular targets of lithium, a drug used for the treatment of bipolar disease (21, 22).”
Backgroundde Mooij-van Malsen, A. (. G. )., van Lith, H. A., Oppelaar, H., Hendriks, J., de Wit, M., Kostrzewa, E., Breen, G., Collier, D. A., Olivier, B., & Kas, M. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.016 · Cited by 58
Chen, X., Cao, H., Saraf, A., Zweifel, L. S., & Storm, D. R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2478-14.2015 · Cited by 21
“Valproate decreases cAMP levels in the brain (Chen et al., 1996; Gould et al., 2004; Chiu et al., 2013) probably by stimulating cAMP phosphodiesterase activity (Gallagher et al.”
BackgroundRapoport, S. I., & Hibbeln, J. R. (2020) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102118 · Cited by 11
Metadata
- Authors
- Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., & Manji, H. K.
- Venue
- Molecular Psychiatry
- Published
- 2004-05-11
- Volume
- 9
- Issue
- 8
- Pages
- 734-755
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2052655524
- Cited by
- 238
- References
- 237
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.